AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis

RecruitingNAAges 18 Years - anyAllUniversitaire Ziekenhuizen KU Leuven
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The risk for colon cancer in patients with longstanding ulcerative colitis exceeding the rectum is increased and therefore patients should be enrolled in a surveillance program eight years after the diagnosis. Until today, official international guidelines for endoscopic screening in patients with ulcerative colitis advise to take 4 biopsies every 10 centimeters (with a minimum of 32) and of each suspected visible lesion. These guidelines are merely based on consensus during expert opinion meetings rather than evidence based. Recent studies have shown that chromo-endoscopy guided biopsies significantly reduced the number of biopsies for each procedure and detected more neoplastic lesions. Chromo-endoscopy is therefore considered the gold standard in this study in which we want to compare it to the performance and efficiency of new endoscopic imaging techniques. Narrow-Band Imaging (NBI)

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with longstanding ulcerative colitis ( 8 years after diagnosis or pancolitis and 10 years after diagnosis of left-sided colitis) * Signed informed consent form * Previous surveillance endoscopy \> 1 year Exclusion Criteria: * Active ulcerative colitis, \> 20 cm from the margo ani * Personal history of colorectal cancer * Allergy or intolerance to methylene blue * Refusing or incapable to agree with informed consent * Age younger than 18 years * Pregnant women
๐Ÿ’Š

What it tests

  • Virtual chromoendoscopy
  • Chromoendoscopy
๐Ÿ“

Where

5 sites
University Hospitals Leuven
Leuven, Belgium
H.-Hartziekenhuis Roeselare-Menen VZW
Roeselaere, Belgium
McGill University Health Center
Montreal, Canada
Copenhagen University Hospital Herlev
Copenhagen, Denmark
Academic Medical center Maastricht
Maastricht, Netherlands
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy